TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11470339

Group type: EXPERIMENTAL
Intervention: Committed Quitters Program (CQP)
Number of subjects: 3683

Group type: COMPARATOR
Intervention: User's Guide (UG)
Number of subjects: 3683
Study: 9415793

Group type: EXPERIMENTAL
Intervention: PeaceBuilders program (intervention schools)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 7
Study: 8518337

Group type: EXPERIMENTAL
Intervention: Celiprolol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Amiloride-hydrochlorothiazide
Number of subjects: 40
Study: 2433081

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg orally 2 h before and 10 mg at the start of the infusion)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg 3 h before the infusion)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 31822445

Group type: EXPERIMENTAL
Intervention: MINDSET program (multicomponent intervention combining mindfulness and psychoeducation)
Number of subjects: 35
Study: 29543473

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive-behavioral therapy (TF-CBT)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: TF-CBT
Number of subjects: 156
Study: 27334415

Group type: EXPERIMENTAL
Intervention: Rejection treatment including ATG
Number of subjects: 361

Group type: COMPARATOR
Intervention: Deceased donor kidney transplant
Number of subjects: 361

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 361
Study: 23416349

Group type: EXPERIMENTAL
Intervention: Activity monitoring using an accelerometer (ACC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 3-day activity recall questionnaire (3-DR)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Heart rate (HR) monitor
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Accelerometer (ACC) and 3-day activity recall questionnaire (3-DR)
Number of subjects: 24
Study: 23705229

Group type: EXPERIMENTAL
Intervention: High-similarity condition
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Low-similarity condition
Number of subjects: 63
Study: 20180787

Group type: EXPERIMENTAL
Intervention: OCA (omeprazole, clarithromycin, amoxicillin)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: OLA (omeprazole, levofloxacin, amoxicillin)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: OACM (omeprazole, amoxicillin for 5 days, followed by omeprazole, clarithromycin, metronidazole for 5 days)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: OALM (omeprazole, levofloxacin, amoxicillin for 5 days, followed by omeprazole, levofloxacin, metronidazole for 5 days)
Number of subjects: 460
Study: 18706008

Group type: EXPERIMENTAL
Intervention: i.v./i.a. rt‐PA therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: i.v. rt‐PA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both treatment arms (i.v./i.a. rt‐PA and i.v. rt‐PA)
Number of subjects: 0
Study: 16798444

Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine 30 mg diluted to 5 mL (group 5)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine 30 mg diluted to 10 mL (group 10)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine 30 mg diluted to 20 mL (group 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine (all groups)
Number of subjects: 60
Study: 14672297

Group type: EXPERIMENTAL
Intervention: Meat
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Energy
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Milk
Number of subjects: 555

Group type: COMPARATOR
Intervention: Control
Number of subjects: 555
Study: 10404948

Group type: EXPERIMENTAL
Intervention: AGT 235T allele presence
Number of subjects: 187

Group type: COMPARATOR
Intervention: Dietary salt intake (high and low)
Number of subjects: 187
Study: 7886996

Group type: EXPERIMENTAL
Intervention: Scintigraphic examination in patients with thigh pain
Number of subjects: 70

Group type: COMPARATOR
Intervention: Scintigraphic examination in patients without thigh pain
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Radiological analysis in both groups
Number of subjects: 70
Study: 2334776

Group type: EXPERIMENTAL
Intervention: Flash preceding sound by 40 milliseconds (AV40)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Simultaneous flash-click (AV)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Click (A)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Flash (V)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Flash preceding sound by 80 milliseconds (AV80)
Number of subjects: 5
Study: 7356683

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 30237250

Group type: EXPERIMENTAL
Intervention: Colon polyps (in premenopausal women)
Number of subjects: 2004

Group type: EXPERIMENTAL
Intervention: Hysterectomy (in premenopausal women)
Number of subjects: 2004

Group type: EXPERIMENTAL
Intervention: Endometriosis (in premenopausal women)
Number of subjects: 2004

Group type: EXPERIMENTAL
Intervention: Coronary artery disease (CVD) (in premenopausal women)
Number of subjects: 2004

Group type: EXPERIMENTAL
Intervention: Osteoporosis (in postmenopausal women)
Number of subjects: 2004

Group type: EXPERIMENTAL
Intervention: Hypercholesterolemia (in postmenopausal women)
Number of subjects: 2004

Group type: EXPERIMENTAL
Intervention: Osteoarthritis (in postmenopausal women)
Number of subjects: 2004

Group type: EXPERIMENTAL
Intervention: History of inflammatory bowel disease (in postmenopausal women)
Number of subjects: 2004
Study: 27001444

Group type: EXPERIMENTAL
Intervention: ONO-4232 (0.08 ng/kg/min)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: ONO-4232 (0.15 ng/kg/min and above)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: ONO-4232 (various doses)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 24198221

Group type: EXPERIMENTAL
Intervention: Vigantol oil (1904 IU once a week)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 86

Group type: COMPARATOR
Intervention: Vigantol oil (1904 IU once a week) and Placebo oil
Number of subjects: 86
Study: 22508200

Group type: EXPERIMENTAL
Intervention: HES (130/0.4) 20 ml/kg + Tranexamic Acid (TA) 10 mg/kg over 30 minutes followed by 1 mg/kg/hr for 12 hours
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ringer's lactate + TA at same dose
Number of subjects: 100

Group type: COMPARATOR
Intervention: HES (130/0.4) 20 ml/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ringer's lactate
Number of subjects: 100
Study: 20856830

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg
Number of subjects: 89

Group type: COMPARATOR
Intervention: Salbutamol 200 μg
Number of subjects: 89

Group type: COMPARATOR
Intervention: Salmeterol-fluticasone 50/500 μg
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 19235434

Group type: EXPERIMENTAL
Intervention: Intravesical mitomycin C chemotherapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Intravesical BCG immunotherapy
Number of subjects: 96
Study: 16698140

Group type: EXPERIMENTAL
Intervention: VO2000 calorimeter
Number of subjects: 33

Group type: COMPARATOR
Intervention: DELTATRAC
Number of subjects: 33
Study: 12842524

Group type: EXPERIMENTAL
Intervention: Preoperative steroid treatment (protocol group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No steroid treatment (control group)
Number of subjects: 20
Study: 10595648

Group type: EXPERIMENTAL
Intervention: Fish oil supplement (20 ml per day, equivalent to 0.3 g omega‐6, 3.6 g omega‐3; omega‐6/omega‐3 ratio 0.1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Soy lecithin supplement (25 g per day, equivalent to 1.5 g omega‐6, 0.5 g omega‐3; omega‐6/omega‐3 ratio 3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (usual diet without any supplement)
Number of subjects: 60
Study: 8932555

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control (delayed treatment)
Number of subjects: 77
Study: 1954453

Group type: EXPERIMENTAL
Intervention: Acetylcysteine
Number of subjects: 50

Group type: COMPARATOR
Intervention: 5% dextrose (Control)
Number of subjects: 50
Study: 7041935

Group type: EXPERIMENTAL
Intervention: 160 mg long acting (LA) propranolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: LA propranolol with carbimazole
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: LA propranolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: LA propranolol and carbimazole
Number of subjects: 20

Group type: COMPARATOR
Intervention: Carbimazole therapy
Number of subjects: 20
Study: 6377221

Group type: EXPERIMENTAL
Intervention: Oral diuretics (chlorothiazide, 20 mg/kg/dose and spironolactone, 1.5 mg/kg/dose, given twice daily)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral diuretics
Number of subjects: 10
Study: 31563947

Group type: EXPERIMENTAL
Intervention: Basal diet top‐dressed with 19 g of the DFM (PROB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Basal diet with no additive (CON)
Number of subjects: 40
Study: 29625529

Group type: EXPERIMENTAL
Intervention: Endobronchial coils
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 0
Study: 26882921

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia supplemented with General Anesthesia (EpiGA)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 62
Study: 24769295

Group type: EXPERIMENTAL
Intervention: Reduced fat plus spice (RFS)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Full fat (FF)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Reduced fat with no added spice (RF)
Number of subjects: 148
Study: 22795099

Group type: EXPERIMENTAL
Intervention: 35 mg soy extract daily for 24 weeks
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 70 mg soy extract daily for 24 weeks
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 35 mg soy extract after 6 months
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 70 mg soy extract after 6 months
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 35 mg soy extract in patients with high bone turnover after 6 months
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 70 mg soy extract in patients with high bone turnover after 6 months
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups after 6 months
Number of subjects: 130
Study: 20626946

Group type: EXPERIMENTAL
Intervention: e‐Chasqui laboratory information system
Number of subjects: 76

Group type: COMPARATOR
Intervention: paper system
Number of subjects: 76
Study: 18806043

Group type: EXPERIMENTAL
Intervention: IV infusion of phenylephrine and ephedrine combined in a 100% phenylephrine ratio
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: IV infusion of phenylephrine and ephedrine combined in a 75% phenylephrine ratio
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: IV infusion of phenylephrine and ephedrine combined in a 50% phenylephrine ratio
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: IV infusion of phenylephrine and ephedrine combined in a 25% phenylephrine ratio
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: IV infusion of phenylephrine and ephedrine combined in a 0% phenylephrine ratio (100% ephedrine)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Phenylephrine alone (control)
Number of subjects: 125
Study: 15758912

Group type: EXPERIMENTAL
Intervention: Allopurinol (600 mg) administered orally at 15 and 3 hours before ERCP
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Allopurinol (600 mg)
Number of subjects: 243
Study: 11803347

Group type: EXPERIMENTAL
Intervention: Autologous blood injection (10-20 ml) beneath the staple line
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (only staplers applied)
Number of subjects: 16
Study: 10411851

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg BID
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Losartan 25 mg BID
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hoe‐140 (bradykinin antagonist) after enalapril
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hoe‐140 (bradykinin antagonist) after losartan
Number of subjects: 12
Study: 7769294

Group type: EXPERIMENTAL
Intervention: Daily primaquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily doxycycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekly mefloquine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chloroquine plus proguanil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Daily vitamin alone
Number of subjects: 0
Study: 2178964

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (0.15 mg.kg‐1 x 2; 30 min apart) (n = 87)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Intravenous salbutamol (5 micrograms.kg‐1) (n = 89)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Theophylline (3‐6 mg.kg‐1) infused i.v. 60 min after salbutamol treatment
Number of subjects: 176

Group type: COMPARATOR
Intervention: Cross-over study on 18 patients
Number of subjects: 176
Study: 6776300

Group type: EXPERIMENTAL
Intervention: Orally administered zomepirac sodium at 100 mg
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Orally administered zomepirac sodium at 200 mg
Number of subjects: 109

Group type: COMPARATOR
Intervention: IM administered morphine sulfate at 8 mg
Number of subjects: 109
Study: 30719796

Group type: EXPERIMENTAL
Intervention: Intervention to increase perceived control over pain
Number of subjects: 228

Group type: COMPARATOR
Intervention: Pain
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Perceived control over pain
Number of subjects: 228
Study: 28286249

Group type: EXPERIMENTAL
Intervention: Respiratory muscle stretching (TG)
Number of subjects: 28
Study: 28269449

Group type: EXPERIMENTAL
Intervention: Implantable gastric electric stimulator with automatic daily activity compliance reporting
Number of subjects: 4
Study: 24829951

Group type: EXPERIMENTAL
Intervention: Problem-Solving Therapy (PST)
Number of subjects: 970

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 970
Study: 22430968

Group type: EXPERIMENTAL
Intervention: PA-824 50 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PA-824 100 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PA-824 150 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PA-824 200 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: HRZE (Control)
Number of subjects: 15
Study: 18848765

Group type: EXPERIMENTAL
Intervention: Subcutaneous (SQ) Acthar Gel (20 units)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous (SQ) Acthar Gel (80 units)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular (IM) Acthar Gel (20 units)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular (IM) Acthar Gel (80 units)
Number of subjects: 0
Study: 17449974

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser therapy combined with SRP
Number of subjects: 10

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 10
Study: 15678732

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 57
Study: 11122543

Group type: EXPERIMENTAL
Intervention: Argatroban (100 microg/kg bolus plus 3 microg/kg/min infusion for 72 hours)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Heparin (5000 U intravenous bolus, 1000 U/h infusion)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Argatroban
Number of subjects: 117

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Argatroban and alteplase
Number of subjects: 117
Study: 9352988

Group type: EXPERIMENTAL
Intervention: Chronic vasodilator therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Discontinuation of vasodilators
Number of subjects: 45
Study: 8441105

Group type: EXPERIMENTAL
Intervention: Procedure A (two fractional doses after removal from ventilator)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Procedure B (two fractional doses through a neonatal suction valve without removal from ventilator)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Procedure C (four fractional doses during removal from ventilator)
Number of subjects: 299
Study: 2887195

Group type: EXPERIMENTAL
Intervention: Terfenadine 60 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31042301

Group type: COMPARATOR
Intervention: SAPP training
Number of subjects: 39

Group type: COMPARATOR
Intervention: SAPP + PERT training
Number of subjects: 39
Study: 28259274

Group type: EXPERIMENTAL
Intervention: Ethyl chloride spray
Number of subjects: 151

Group type: COMPARATOR
Intervention: Routine injection (no topical spray)
Number of subjects: 151
Study: 26210612

Group type: EXPERIMENTAL
Intervention: X:IT multi-component school-based programme
Number of subjects: 4041

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 4041
Study: 23954277

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: GCSB-5
Number of subjects: 198
Study: 21658093

Group type: EXPERIMENTAL
Intervention: Suspension formulation of omeprazole in 8.4% sodium bicarbonate
Number of subjects: 10

Group type: COMPARATOR
Intervention: MUPS® formulation of omeprazole disintegrated in water
Number of subjects: 10
Study: 18083272

Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study: 16427852

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass grafting (OPCAB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional on-pump coronary artery bypass grafting (CABG)
Number of subjects: 50
Study: 12968636

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 0
Study: 10930970

Group type: EXPERIMENTAL
Intervention: Intervention group (medicine review and education programme)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention group (medicine education)
Number of subjects: 0
Study: 9364949

Group type: EXPERIMENTAL
Intervention: 60% w/v barium sulfate plus 2.5% w/v bentonite
Number of subjects: 20

Group type: COMPARATOR
Intervention: 220% w/v barium sulfate
Number of subjects: 20
Study: 8222684

Group type: EXPERIMENTAL
Intervention: Selective digestive decontamination (oral antibiotics: polymyxin E, tobramycin, and amphotericin B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 80
Study: 3096221

Group type: EXPERIMENTAL
Intervention: Mupirocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 31413010

Group type: EXPERIMENTAL
Intervention: Gefitinib plus metformin
Number of subjects: 224

Group type: COMPARATOR
Intervention: Gefitinib plus placebo
Number of subjects: 224
Study: 29030864

Group type: EXPERIMENTAL
Intervention: Ingenol mebutate 0·015% gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diclofenac sodium 3% gel
Number of subjects: 0
Study: 28086200

Group type: EXPERIMENTAL
Intervention: Cryotherapy with liquid nitrogen
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 180
Study: 25429531

Group type: EXPERIMENTAL
Intervention: HC-A II
Number of subjects: 277

Group type: COMPARATOR
Intervention: HTK
Number of subjects: 277
Study: 23653899

Group type: EXPERIMENTAL
Intervention: CoJet Sand
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Lava Ceram liner
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Intensive ZirLiner
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Panavia F
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: RelyX Unicem
Number of subjects: 72

Group type: COMPARATOR
Intervention: Nontreated specimens
Number of subjects: 72

Group type: COMPARATOR
Intervention: Specimens treated with CoJet Sand
Number of subjects: 72

Group type: COMPARATOR
Intervention: Specimens treated with liners
Number of subjects: 72
Study: 20951323

Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness (measured in METs)
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness added to conventional risk factors
Number of subjects: 2368
Study: 18412566

Group type: EXPERIMENTAL
Intervention: Aged and menopaused receiving hormonal replacement therapy
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Aged and menopaused
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Aged with normal menses
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Young with normal menses
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 4
Study: 16357330

Group type: EXPERIMENTAL
Intervention: Minocycline pleurodesis (103 patients)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Observation (99 patients)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Minocycline pleurodesis
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Minocycline pleurodesis and Observation
Number of subjects: 202
Study: 14594941

Group type: EXPERIMENTAL
Intervention: Chemotherapy with supportive care to control non-hematological adverse events (nausea/vomiting, anorexia, diarrhea)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 377

Group type: COMPARATOR
Intervention: Control of non-hematological adverse events
Number of subjects: 377
Study: 10919591

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 1 g twice daily (n=34)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA) 2 mg/kg (n=30)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Dose reduction of MMF to 500 mg twice daily
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Dose reduction of AZA to 1.0 mg/kg
Number of subjects: 64

Group type: COMPARATOR
Intervention: Both groups (MMF and AZA)
Number of subjects: 64
Study: 8160596

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillators (ICDs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimal medical therapy (amiodarone)
Number of subjects: 0
Study: 3168726

Group type: EXPERIMENTAL
Intervention: Sorbinil (250 mg/day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19